BCCM
Blue Clay Capital Management’s Ligand Pharmaceuticals LGND Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q3 | $1.75M | Buy |
17,125
+1,000
| +6% | +$102K | 1.97% | 5 |
|
|
2016
Q2 | $1.92M | Sell |
16,125
-1,500
| -9% | -$179K | 2.24% | 4 |
|
|
2016
Q1 | $1.89M | Sell |
17,625
-2,550
| -13% | -$273K | 1.78% | 8 |
|
|
2015
Q4 | $2.19M | Sell |
20,175
-2,000
| -9% | -$217K | 1.81% | 5 |
|
|
2015
Q3 | $1.9M | Sell |
22,175
-3,500
| -14% | -$300K | 1.51% | 11 |
|
|
2015
Q2 | $2.59M | Sell |
25,675
-11,000
| -30% | -$1.11M | 1.47% | 7 |
|
|
2015
Q1 | $2.83M | Sell |
36,675
-4,925
| -12% | -$380K | 1.48% | 7 |
|
|
2014
Q4 | $2.21M | Buy |
+41,600
| New | +$2.21M | 1.62% | 6 |
|